<DOC>
	<DOCNO>NCT00213902</DOCNO>
	<brief_summary>The objective study : 1 . To evaluate effect clonidine , sympathetic modulator , reverse cardiac remodel improve hemodynamics diastolic heart failure ( DHF ) . 2 . To evaluate effect clonidine neurohormone quality life patient DHF . The study double-blind , placebo-controlled study evaluate effect clonidine compare placebo patient DHF . A total 70 patient DHF randomize 1:1 ratio : 1. placebo ( n=35 ) 2. clonidine ( n=35 ) dose 0.075 mg twice day first 6 week follow uptitration 0.150 mg twice day 6 month . The primary outcome reversion cardiac remodel hemodynamic parameter evaluate magnetic resonance imaging ( MRI ) echocardiography .</brief_summary>
	<brief_title>Clonidine Left Ventricular Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Age : 60 great Gender : Both Patients heart failure New York Heart Association ( NYHA ) II ejection fraction 45 %</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Diastolic</keyword>
	<keyword>functionClonidine</keyword>
	<keyword>Left ventricular diastolic dysfunction preserve ejection fraction</keyword>
</DOC>